Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/09/2010US20100227845 Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
09/09/2010US20100227844 Cannabinoid-1 receptor modulators useful for the treatment of alzheimer's disease
09/09/2010US20100227843 Beta-lactamase-resistant cephalosporin ester compounds and salts of thereof
09/09/2010US20100227842 Methods for treating ocular inflammatory diseases
09/09/2010US20100227841 Patient populations and treatment methods
09/09/2010US20100227840 Use of 25-hydroxy vitamin d3 to improve male animal fertility
09/09/2010US20100227839 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
09/09/2010US20100227838 Combination Therapy for Treating Cancer and Diagnostic Assays for Use Therein
09/09/2010US20100227836 Parenteral administration of a glucosamine
09/09/2010US20100227835 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
09/09/2010US20100227834 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy
09/09/2010US20100227833 Novel nucleoside analogs for treatment of viral infections
09/09/2010US20100227832 Modulation of telomere length in telomerase positive cells and cancer therapy
09/09/2010US20100227831 Compositions and methods for cancer treatment
09/09/2010US20100227830 Use of escin
09/09/2010US20100227829 Motilide polymorphs
09/09/2010US20100227828 New synergistic phytochemical composition for the treatment of obesity
09/09/2010US20100227827 Method of increasing tryptophan and nicotinamide levels in vivo
09/09/2010US20100227826 Stable Flavonoid Solutions
09/09/2010US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
09/09/2010US20100227812 Method of supplementing the diet and ameliorating oxidative stress
09/09/2010US20100227811 Farnesylamine derivatives and methods of use
09/09/2010US20100227804 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier
09/09/2010US20100227801 Pharmaceutical compositions
09/09/2010US20100227800 Triazole derivatives as kinase inhibitors
09/09/2010US20100227799 Simultaneous photodynamic therapy and photo induced polymerization
09/09/2010US20100227798 Use of the staudinger ligation in in vivo assembly of a biologically active compound
09/09/2010US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
09/09/2010US20100227791 Compounds Having Antitumor Activity
09/09/2010US20100227762 Active ingredient combinations with insecticidal properties
09/09/2010US20100227418 Method and kit for detecting the early onset of renal tubular cell injury
09/09/2010US20100227354 Autoimmune Conditions and NADPH Oxidase Defects
09/09/2010US20100227005 Methods to treat and/or prevent mucositis
09/09/2010US20100227001 Method of delivering nutrients
09/09/2010US20100226999 Process for forming stabilized ophthalmic solutions
09/09/2010US20100226996 Compositions and methods of delivery of pharmacological agents
09/09/2010US20100226995 Microencapsulated bioactive agents for oral delivery and methods of use thereof
09/09/2010US20100226994 Granule, tablet and methods for producing the same
09/09/2010US20100226993 Composition for regenerative treatment of cartilage disease
09/09/2010US20100226992 Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
09/09/2010US20100226991 Solid inorganic/organic hybrid with modified surface
09/09/2010US20100226990 Method of Producing Porous Microparticles
09/09/2010US20100226989 Nanoparticulate megestrol formulations
09/09/2010US20100226987 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
09/09/2010US20100226986 Therapeutic Particles Suitable for Parenteral Administration and Methods of Making and Using Same
09/09/2010US20100226983 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
09/09/2010US20100226982 Stabilized Active Ingredient Composition
09/09/2010US20100226981 Oral dosage forms having a high loading of a gabapentin prodrug
09/09/2010US20100226980 Novel tablet based on s-adenosyl-methionine
09/09/2010US20100226979 Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
09/09/2010US20100226978 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
09/09/2010US20100226977 Low viscosity phospholipid compositions
09/09/2010US20100226972 Transdermal pain gel
09/09/2010US20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/09/2010US20100226967 Imaging and therapeutic method using progenitor cells
09/09/2010US20100226965 Compositions & methods for wound healing
09/09/2010US20100226964 Highly Compactable and durable direct compression excipients and excipient systems
09/09/2010US20100226963 Bi-functional co-polymer use for opthalmic and other topical and local applications
09/09/2010US20100226960 Natural biodegradable matrices and uses thereof
09/09/2010US20100226955 Polymer for creating hemocompatible surface
09/09/2010US20100226948 Methods and compositions for treating acne
09/09/2010US20100226947 Articles of manufacture releasing an active ingredient
09/09/2010US20100226945 Dye-free pharmaceutical suspensions and related methods
09/09/2010US20100226944 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process
09/09/2010US20100226941 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/09/2010US20100226918 Pyrrole derivatives as p2y12 antagonists
09/09/2010US20100226915 AGER-Peptides and Use Thereof
09/09/2010US20100226913 Therapeutic Compositions Comprising Monoterpenes
09/09/2010US20100226911 Treating or preventing extracellular matrix build-up
09/09/2010US20100226908 Compositions for promoting wound healing and treating psoriasis
09/09/2010US20100226900 Prevention and treatment of osteochondrosis in animals and humans
09/09/2010US20100226886 Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C
09/09/2010US20100226883 Linked diimidazole derivatives
09/09/2010US20100226882 Linked diimidazole antivirals
09/09/2010US20100226881 PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY
09/09/2010US20100226880 Treatment with anti-vegf antibodies
09/09/2010US20100226879 Heterocyclic antiviral compounds
09/09/2010US20100226878 Methods of inhibiting photoreceptor apoptosis
09/09/2010US20100226873 Hemostatic Composition with Magnetite
09/09/2010US20100226871 High intensity fragrances
09/09/2010US20100226870 Use of creatine or creatine compounds for skin preservation
09/09/2010US20100226864 Alkyl-substituted tetrahydropyrans as flavoring substances
09/09/2010US20100226858 Method of predicting a predisposition to qt prolongation
09/09/2010US20100226857 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
09/09/2010US20100226855 Rate-Controlled Oral Dosage Formulations
09/09/2010DE202010006543U1 Erlotinibresinat Erlotinibresinat
09/09/2010DE102009011264A1 New ecdysone compounds useful for treating age-related diseases such as osteoporosis, osteoarthritis, incontinence, obesity, arteriosclerosis, hypertonus, metabolic syndrome, anemias, hyperandrogenemia, cellulite and menopausal hot flushes
09/09/2010DE102009001283A1 Mineralocorticoid receptor antagonist, useful for reducing the myocardial infarction with reperfusion
09/09/2010CA2696213A1 Tolperisone controlled release tablet
09/08/2010EP2226388A1 Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same
09/08/2010EP2226329A1 Metal-containing platensimycin analogues
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226323A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/08/2010EP2226322A1 Imidazole carbonyl compound
09/08/2010EP2226321A2 Process for producing thiazolidinediones and intermediates thereof
09/08/2010EP2226320A1 Process for production of heterocycle-substituted pyridine derivative
09/08/2010EP2226318A2 Dye-Azide compounds for dual photherapy
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2226085A1 Anti-angiogenic compositions and methods of use
1 ... 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 ... 7860